Pebble Accelerator

Great Bay Bio Ltd. is a biotechnology company based in Central Hong Kong, founded in 2002. The company specializes in drug discovery and contract research services, leveraging artificial intelligence within its Chemistry, Manufacturing, and Control (CMC) platform to enhance drug development processes. Great Bay Bio is involved in the research, development, and manufacturing of protein sequence products, including recombinant insulin-stimulating hormones and fusion proteins. With a focus on biopharmaceutical innovation, the company utilizes a digital platform that integrates AI technology, big data, and Internet of Things technology to streamline the drug development cycle and reduce costs. By aligning with national strategies for scientific innovation and fostering collaboration across regions such as Europe, the United States, Singapore, and Hong Kong, Great Bay Bio aims to enhance its competitive edge in the biopharmaceutical industry.